Skip to content
Riskpilot
← Back to search
Sign in
Get full access
SIMULPHARMA ApS
APS
Active
Advertising protection
CVR 32832075
Nobis Mølle 33, 3460
Birkerød
Wholesale of other machinery and equipment
·
NACE 4664
Est. 2010 · 16 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of other machinery and equipment
/
SIMULPHARMA ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
719
636
484
115
159
Staff expenses
-0
-0
-0
-0
-0
EBITDA
43
-84
-58
-57
41
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
43
-84
-58
-57
41
Net financials
-0
-1
-0
0
0
Profit before tax
43
-85
-58
-57
41
Tax
6
-2
-0
-0
-0
Net profit
36
-83
-58
-57
41
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
245
138
90
22
76
Equity
221
138
80
22
64
Long-term debt
0
0
0
0
0
Short-term debt
24
0
11
0
13
Total debt
24
0
11
0
13
Financial ratios
5-year trend
EBITDA margin
25.9%
This company
15.8%
Market median
+64% vs market
2020
2024
Equity ratio
83.5%
This company
38.2%
Market median
+119% vs market
2020
2024
Return on equity
64.8%
This company
18.4%
Market median
+252% vs market
2020
2024
Net profit margin
26.0%
This company
8.1%
Market median
+221% vs market
2020
2024
Asset turnover
2.08×
This company
1.12×
Market median
+86% vs market
2020
2024
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on SIMULPHARMA ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
